120-71-8|2-Methoxy-5-methylaniline - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

2-Methoxy-5-methylaniline | CAS:120-71-8

2-Methoxy-5-methylaniline

Name：2-Methoxy-5-methylaniline
CAS：120-71-8
Synonyms：5-Methyl-o-anisidine; p-Cresidine; 6-Methoxy-m-toluidine; C.I. Azoic Red 83
Molecular Formula：C₈H₁₁NO
Molecular Weight：137.18
EINESC：204-419-1

Description

Properties

Melting point	49-55 ºC
Water Solubility	略溶于热水.
Boiling point	235 ºC
Flash point	111 ºC

Safety

Symbol(GHS)	T
Hazard Codes	R22;R45
SDS/MSDS	S45;S53

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

The methanol extract of Euonymus laxiflorus, Rubia lanceolata and Gardenia jasminoides inhibits xanthine oxidase and reduce serum uric acid level in rats.Li-Min Liu et al.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 70, 179-184 (2014-05-23) Erding Formula in hyperuricaemia treatment: unfolding traditional Chinese herbal compatibility using modern pharmaceutical approaches.Jieyu Zuo et al.The Journal of pharmacy and pharmacology, 70(1), 124-132 (2017-10-24) Administered chrysanthemum flower oil attenuates hyperuricemia: mechanism of action as revealed by DNA microarray analysis.Shinichi Honda et al.Bioscience, biotechnology, and biochemistry, 78(4), 655-661 (2014-07-19) Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.T Shirasaka et al.Cancer research, 53(17), 4004-4009 (1993-09-01) Higher Blood Uric Acid in Female Humans and Mice as a Protective Factor against Pathophysiological Decline of Lung Function.Haruka Fujikawa et al.Antioxidants (Basel, Switzerland), 9(5) (2020-05-10) Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.Kei Nishizawa et al.PloS one, 14(4), e0214862-e0214862 (2019-04-06) Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney.Yasushi Habu et al.Biochemical pharmacology, 69(6), 993-999 (2005-03-08)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News